Results 201 to 210 of about 118,147 (316)
Single‐cell multi‐omics reveals epigenetic heterogeneity across therapy‐adaptive tumor states, including quiescent/dormant, drug‐tolerant persister, and EMT‐like phenotypes. By linking regulatory features with state‐associated biomarkers, these approaches inform biomarker‐guided therapeutic strategies for evolving tumors.
Hee Jung Kim +3 more
wiley +1 more source
Advance in biologics for chronic rhinosinusitis with nasal polyps. [PDF]
Di Y, Zeng R, Huang L, Wu Y, Wu Q.
europepmc +1 more source
Breast cancer remains a major cause of cancer death in women, frequently developing endocrine therapy resistance. This study demonstrates that upregulated p21‐activated kinase 1 (PAK1) activity drives resistance to tamoxifen and long‐term estrogen deprivation in ER+ breast cancer models.
Luisa Schwarzmüller +10 more
wiley +1 more source
Patient Preferences in Hidradenitis Suppurativa Depend on Treatment Experience: Results from APProach-HS. [PDF]
Kromer C +11 more
europepmc +1 more source
RoboMic is an automated confocal microscopy pipeline for high‐throughput functional imaging in living cells. Demonstrated with fluorescence recovery after photobleaching (FRAP), it integrates AI‐driven nuclear segmentation, ROI selection, bleaching, and analysis.
Selçuk Yavuz +6 more
wiley +1 more source
Vaccinating patients on biologics for atopic disease: Clinical considerations and evidence-based recommendations. [PDF]
Chase NM.
europepmc +1 more source

